Conditions: Curative Breast Cancer Surgery Inflammatory Positive/Negative Status Pre Surgical Incision Administration
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 203
Healthy volunteers: no

Brief summary:
Do the use of Ketorolac in one intravenous injection at the moment of the operative incision reduce the number of recurrence in patient with advanced breast cancer without inflammation signs.

Detailed description:

Arms:
arm 1: Active drug to be compared with placebo arm 2: Placebo looking like the Active drug

Interventions: intervention 1: Ketorolac 30 mg IV intervention 2: Placebos
Intervention descriptions: intervention 1: Active drug intervention 2: Placebo looking like the Active drug

Protocol document: